Sign In
Get Care Now

Tirzepatide

A clinician-guided program using tirzepatide to support appetite regulation and metabolic health when medically appropriate.

Original price was: $86.00.Current price is: $46.00.

  • Licensed medical providers
  • Virtual evaluation
  • Available where permitted by law
Start Assessment

Prescription required. Medical evaluation necessary.

  • Available 24 hours a day, 7 days a week
  • Licensed healthcare providers
  • HIPAA compliant care
  • Confidential and secure

What Is Tirzepatide?

Tirzepatide is a prescription medication that targets GLP-1 and GIP receptors involved in appetite and metabolic regulation.

It may be prescribed as part of a structured medical weight management program after clinician review.

How Tirzepatide Is Used

Under provider supervision, tirzepatide may be prescribed to:
  • Supports appetite regulation
  • Help promote satiety
  • Support metabolic balance
  • Complement a personalized care plan

How Tirzepatide Therapy Step

Secure Assessment

Complete a confidential medical intake.

Clinician Review

Licensed provider evaluates eligibility and appropriateness.

Personalized Plan

Treatment plan created when medically appropriate.

Ongoing Support

Follow-up and adjustments as needed.

Why Choose PanaceaCareTM?

Our approach prioritizes clinical oversight, transparency, and continuity of care.

Clinician Review Required

Ongoing Provider Monitoring

HIPAA-Compliant Platform

Licensed Pharmacy Fulfillment

Transparent Starting Pricing

Others

Clinician Review Required

Others

Ongoing Provider Monitoring

Others

HIPAA-Compliant Platform

Others

Licensed Pharmacy Fulfillment

Others

Transparent Starting Pricing

Others

Frequently Asked Questions

What is tirzepatide?

Tirzepatide is a prescription medication that works on GLP-1 and GIP receptors involved in appetite and metabolic regulation. It may be considered as part of a clinician-guided weight management plan.

Eligibility is determined after a medical evaluation that reviews health history, medications, and risk factors.

Tirzepatide is typically administered as a once-weekly subcutaneous injection when prescribed.

Treatment duration varies by individual and is based on clinical response and provider guidance.

No. Individual responses vary. Treatment decisions are personalized and monitored over time.

document.addEventListener("DOMContentLoaded", function () { const accordion = document.querySelector(".elementor-element-63edfe6"); if (!accordion) return; const items = accordion.querySelectorAll(".e-n-accordion-item"); items.forEach(item => { const title = item.querySelector(".e-n-accordion-item-title-text"); const content = item.querySelector('[role="region"]'); const titleEmpty = !title || !title.textContent.trim(); const contentEmpty = !content || !content.textContent.trim(); if (titleEmpty || contentEmpty) { item.remove(); } }); });
document.addEventListener("DOMContentLoaded", function () { // Change heading const heading = document.querySelector( '.elementor-element-8bb4063 .elementor-heading-title' ); if (heading) { heading.textContent = "Explore Care Designed Around You"; } // Change paragraph text const paragraph = document.querySelector( '.elementor-element-8bb4063 .elementor-widget-text-editor p' ); if (paragraph) { paragraph.textContent = "Begin your secure assessment and connect with a licensed healthcare professional to explore your care options."; } });